Zhao Liu
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
-
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 26
- Cancer Cells and Metastasis 10
- Pancreatic and Hepatic Oncology Research 10
- Cancer Immunotherapy and Biomarkers 3
-
- Epigenetics and DNA Methylation 4
- Co-authors
- Xin Cheng (1 shared paper)Lemei Zhu (1 shared paper)Weijun Peng (1 shared paper)Hongli Li (1 shared paper)Zhen Zhang (1 shared paper)Di Zhao (1 shared paper)Jianhua Huang (1 shared paper)Abhik Bandyopadhyay (2 shared papers)
- Journals
- Cancer Research (2 papers)Frontiers in Oncology (2 papers)World Journal of Gastroenterology (2 papers)Scientific Reports (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Zhao Liu
42 papers receiving 444 citations
Zhao Liu's Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 95
- Oncology 167
- Biological Psychiatry 13
- Molecular Biology 162
- Endocrinology, Diabetes and Metabolism 33
Countries citing papers authored by Zhao Liu
This map shows the geographic impact of Zhao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao Liu more than expected).
Fields of papers citing papers by Zhao Liu
This network shows the impact of papers produced by Zhao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao Liu. The network helps show where Zhao Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhao Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quercetin: A promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis Hit paper breakdown → | 2023 | 141 |
| 2 | 2012 | 34 | |
| 3 | 2015 | 22 | |
| 4 | 2017 | 22 | |
| 5 | 2021 | 20 | |
| 6 | 2022 | 19 | |
| 7 | 2015 | 16 | |
| 8 | 2012 | 14 | |
| 9 | 2021 | 13 | |
| 10 | 2023 | 13 | |
| 11 | Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune suppression by downregulating PD-L1 expression in pancreatic cancer. | 2023 | 13 |
| 12 | 2022 | 12 | |
| 13 | 2015 | 11 | |
| 14 | 2016 | 11 | |
| 15 | 2019 | 9 | |
| 16 | 2020 | 8 | |
| 17 | 2023 | 7 | |
| 18 | 2020 | 5 | |
| 19 | 2020 | 5 | |
| 20 | 2022 | 5 |
About Zhao Liu
Zhao Liu is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 43 papers that have together received 446 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (10 papers), Pancreatic and Hepatic Oncology Research (10 papers), Renal cell carcinoma treatment (4 papers), Ferroptosis and cancer prognosis (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (95 citations), Oncology (167 citations), Biological Psychiatry (13 citations), Molecular Biology (162 citations) and Endocrinology, Diabetes and Metabolism (33 citations). Zhao Liu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Xin Cheng, Lemei Zhu, Weijun Peng, Hongli Li, Zhen Zhang, Di Zhao, Jianhua Huang, Abhik Bandyopadhyay, Norio Uemura and Hiromitsu Hayashi. Their work appears in journals such as Cancer Research, Frontiers in Oncology, World Journal of Gastroenterology, Scientific Reports and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.